This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Notch | |
|---|---|
| Name | Notch |
| Caption | Structure of a Notch receptor |
| Organism | Metazoa |
Notch is a family of single-pass transmembrane receptors that mediate short-range cell–cell communication essential for cell fate decisions, patterning, and tissue homeostasis. Members of the Notch family participate in conserved signaling cascades that coordinate differentiation, proliferation, and apoptosis across metazoan taxa; dysregulation contributes to congenital disorders and neoplasia. Notch receptors interact with membrane-bound ligands to trigger proteolytic cleavage and nuclear transcriptional responses, integrating inputs from pathways including Wnt signaling pathway, Hedgehog signaling pathway, TGF beta signaling pathway, PI3K–Akt pathway and MAPK/ERK pathway.
The name derives from classical genetic work in Drosophila melanogaster where mutations produced a notched wing margin phenotype; early geneticists associated the trait with discrete loci studied alongside genes such as engrailed, hedgehog, wingless and decapentaplegic. Subsequent molecular cloning in labs linked to researchers like Christof Niehrs and groups at institutions such as Harvard University and Massachusetts Institute of Technology established the receptor–ligand paradigm, spawning terminology including "Notch receptors", "DSL ligands" and "NICD" used across literature in journals like Nature and Cell.
Notch receptors are type I transmembrane proteins characterized by extracellular epidermal growth factor-like (EGF) repeats, a negative regulatory region, a single-pass transmembrane domain, and an intracellular domain containing RAM, ankyrin repeats, and PEST sequences. Vertebrates possess paralogs such as NOTCH1, NOTCH2, NOTCH3 and NOTCH4 identified in genomic projects at centers like the Human Genome Project and annotated in databases curated by UniProt and NCBI. Ligands include Delta-like (DLL1, DLL3, DLL4) and Jagged (JAG1, JAG2) families; structural studies employing cryo-electron microscopy at facilities like EMBL and Max Planck Institute clarified receptor–ligand interfaces and glycosylation by Fringe homologs such as Lunatic, Manic and Radical Fringe.
Genetic analyses in model organisms—Drosophila melanogaster, Danio rerio (zebrafish), Mus musculus (mouse) and Caenorhabditis elegans—demonstrated Notch roles in lateral inhibition, boundary formation and somitogenesis. Developmental syndromes mapped to NOTCH loci include mutations discovered through linkage analysis and genome-wide association studies in cohorts at institutions such as NIH and collaborative consortia. Post-translational modifications, notably O-fucosylation by POFUT1 and O-glucosylation by POGLUT1, modulate receptor responsiveness; transcriptional regulation involves co-factors characterized in chromatin studies at laboratories affiliated with Cold Spring Harbor Laboratory and Broad Institute.
Canonical activation requires trans-interaction with DSL ligands on adjacent cells, inducing two sequential proteolytic cleavages by ADAM-family metalloproteases (e.g., ADAM10) and the gamma-secretase complex including presenilin subunits, releasing the Notch intracellular domain (NICD). NICD translocates to the nucleus where it forms a transcriptional activation complex with CSL family DNA-binding proteins (CBF1/RBPJ) and co-activators such as Mastermind-like (MAML), regulating targets including HES and HEY transcription factors implicated in neural development, vascular differentiation and stem cell maintenance studied in contexts like embryonic stem cell culture and organoid models developed at centers including Salk Institute.
Cross-talk integrates signals from pathways such as NF-κB, Hippo signaling pathway, Notch–Wnt interactions and modulatory post-translational environments involving ubiquitin ligases like FBXW7 and endocytic machinery (e.g., Clathrin mediated trafficking) that influence receptor turnover and signaling amplitude.
Germline and somatic alterations in Notch pathway components underlie congenital disorders and cancer. Heterozygous mutations in JAG1 and NOTCH2 cause Alagille syndrome characterized by cholestasis and cardiac defects; CADASIL results from stereotyped missense changes in NOTCH3 producing cerebral small vessel disease and stroke predisposition. Activating NOTCH1 mutations are frequent in T-cell acute lymphoblastic leukemia, while deregulation is implicated in breast cancer, colorectal cancer, non-small-cell lung carcinoma and hepatocellular carcinoma with clinical investigations led by oncology groups at institutions such as MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Therapeutic strategies include gamma-secretase inhibitors, monoclonal antibodies targeting ligands or receptors, and ligand-blocking decoys evaluated in trials registered by agencies like FDA.
Notch signaling is conserved across metazoans from sponges to vertebrates, with orthologs identified in genomes sequenced by the Genome Project consortia and comparative analyses by groups at Wellcome Sanger Institute. Phylogenetic studies reveal expansion into paralogous repertoires in chordates and vertebrates; conservation of EGF repeats, RAM and ankyrin motifs underlies functional conservation, while lineage-specific innovations in ligand repertoires and Fringe-mediated modulation contribute to species-specific patterning differences explored in evolutionary developmental biology by laboratories associated with Max Planck Institute for Developmental Biology and Marine Biological Laboratory.
Experimental approaches include genetic manipulation in Drosophila melanogaster using GAL4/UAS systems, CRISPR/Cas9 genome editing in Mus musculus and Danio rerio, conditional knockouts employing Cre-lox technologies developed in many academic centers, and in vitro assays using co-culture signaling reporters in cell lines such as HEK293 and NIH 3T3. Biochemical studies use gamma-secretase activity assays, co-immunoprecipitation and chromatin immunoprecipitation sequencing (ChIP-seq) performed in core facilities at institutions like Stanford University and University of Cambridge; high-resolution imaging including live-cell confocal microscopy and single-molecule techniques at centers such as Janelia Research Campus provide spatiotemporal insights into receptor trafficking and signal transduction.
Category:Signal transduction proteins